Home > Category > Signaling Pathways > Apoptosis > Bcl-2 > (S)-N-((4-(((1,4-dioxan-2-yl)methyl)amino)-3-nitrophenyl)sulfonyl)-2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-(4-((6-(4-chlorophenyl)spiro[3.5]non-6-en-7-yl)methyl)piperazin-1-yl)benzamide

(S)-N-((4-(((1,4-dioxan-2-yl)methyl)amino)-3-nitrophenyl)sulfonyl)-2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-(4-((6-(4-chlorophenyl)spiro[3.5]non-6-en-7-yl)methyl)piperazin-1-yl)benzamide

ChemLeader 98+%
Catalog No:CL2494 CAS No.:2180923-05-9 MDLNo: Formula:C45H48ClN7O8S MW:882.42
Size Availability Price(USD) VIP Price (USD) Quantity
1 mg 3-5days $625.00 Visible after login
- +
5 mg 3-5days $1625.00 Visible after login
- +

Chemical safety data sheet(MSDS)

Download MSDS
  • Product Overview
  • Related documents
  • Product details
  • Related literature
Product Overview
Product Name (S)-N-((4-(((1,4-dioxan-2-yl)methyl)amino)-3-nitrophenyl)sulfonyl)-2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-(4-((6-(4-chlorophenyl)spiro[3.5]non-6-en-7-yl)methyl)piperazin-1-yl)benzamide
CAS2180923-05-9
FormulaC45H48ClN7O8S
MW882.42
AppearanceLight yellow to yellow powder
Storage condition Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
Product details

Lisaftoclax (Bcl-2/Bcl-xl inhibitor 1; APG2575) is a novel and potent dual inhibitor of Bcl-2 and Bcl-xl with anticancer activity. It inhibits Bcl-2 and Bcl-xl with IC50 of 2 nM and 5.9 nM, respectively.

Related literature
Sorry, there is no relevant literature
Related
Sorry, no related items
Service
ChemLeader
021-58180488
Online service time: 9:00-18:00 on weekdays